GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Accumulated other comprehensive income (loss)

Aptose Biosciences (TSX:APS) Accumulated other comprehensive income (loss) : C$-5.79 Mil (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Aptose Biosciences's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was C$-5.79 Mil.

Aptose Biosciences's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 (C$-5.73 Mil) to Sep. 2023 (C$-5.84 Mil) but then increased from Sep. 2023 (C$-5.84 Mil) to Dec. 2023 (C$-5.79 Mil).

Aptose Biosciences's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (C$-5.52 Mil) to Dec. 2022 (C$-5.87 Mil) but then increased from Dec. 2022 (C$-5.87 Mil) to Dec. 2023 (C$-5.79 Mil).

Aptose Biosciences Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Aptose Biosciences's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Accumulated other comprehensive income (loss) Chart

Aptose Biosciences Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.66 -5.53 -5.52 -5.87 -5.79

Aptose Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.87 -5.90 -5.73 -5.84 -5.79

Aptose Biosciences Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Aptose Biosciences Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences (TSX:APS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
XCNQ:DOSE NEOE:BMND TSXV:COV XCNQ:PHRM TSXV:CZO TSXV:TTI XCNQ:TELI XCNQ:MDMA TSXV:CYTO TSXV:SBM OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
APTO:USA LTI:Germany
Address
251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3
Website
https://www.aptose.com
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences (TSX:APS) Headlines

No Headlines